1. Home
  2. EWTX vs STEL Comparison

EWTX vs STEL Comparison

Compare EWTX & STEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EWTX
  • STEL
  • Stock Information
  • Founded
  • EWTX 2017
  • STEL 2007
  • Country
  • EWTX United States
  • STEL United States
  • Employees
  • EWTX N/A
  • STEL N/A
  • Industry
  • EWTX Biotechnology: Pharmaceutical Preparations
  • STEL Major Banks
  • Sector
  • EWTX Health Care
  • STEL Finance
  • Exchange
  • EWTX Nasdaq
  • STEL Nasdaq
  • Market Cap
  • EWTX 1.2B
  • STEL 1.3B
  • IPO Year
  • EWTX 2021
  • STEL N/A
  • Fundamental
  • Price
  • EWTX $14.70
  • STEL $26.46
  • Analyst Decision
  • EWTX Buy
  • STEL Hold
  • Analyst Count
  • EWTX 8
  • STEL 3
  • Target Price
  • EWTX $40.13
  • STEL $29.00
  • AVG Volume (30 Days)
  • EWTX 1.2M
  • STEL 226.5K
  • Earning Date
  • EWTX 05-08-2025
  • STEL 04-25-2025
  • Dividend Yield
  • EWTX N/A
  • STEL 2.10%
  • EPS Growth
  • EWTX N/A
  • STEL N/A
  • EPS
  • EWTX N/A
  • STEL 2.12
  • Revenue
  • EWTX N/A
  • STEL $430,733,000.00
  • Revenue This Year
  • EWTX N/A
  • STEL $1.97
  • Revenue Next Year
  • EWTX N/A
  • STEL $4.52
  • P/E Ratio
  • EWTX N/A
  • STEL $12.55
  • Revenue Growth
  • EWTX N/A
  • STEL N/A
  • 52 Week Low
  • EWTX $10.60
  • STEL $21.27
  • 52 Week High
  • EWTX $38.12
  • STEL $32.36
  • Technical
  • Relative Strength Index (RSI)
  • EWTX 42.22
  • STEL 54.18
  • Support Level
  • EWTX $14.08
  • STEL $25.48
  • Resistance Level
  • EWTX $17.30
  • STEL $26.09
  • Average True Range (ATR)
  • EWTX 1.00
  • STEL 0.76
  • MACD
  • EWTX 0.39
  • STEL 0.13
  • Stochastic Oscillator
  • EWTX 37.50
  • STEL 64.26

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

About STEL Stellar Bancorp Inc.

Stellar Bancorp Inc is a U.S. based bank holding company. Through its subsidiary, Stellar Bank, the company provides a diversified range of commercial banking services predominantly to small to medium sized businesses, professionals, and individual customers. Its offerings include different types of loans, such as mortgage loans, home equity loans, automobile loans, etc.; deposit products, such as checking accounts, commercial accounts, money market accounts, savings accounts, etc.; and other banking services like mobile banking, debit cards, cash management and wire transfer services, letters of credit, and others.

Share on Social Networks: